webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

N-(2-((2,3-Dihydro-1H-Inden-5-yl)oxy)ethyl)-4-Formylbenzamide

  CAS No.: 1225979-81-6   Cat No.: BADC-00540 4.5  

N-(2-((2,3-Dihydro-1H-Inden-5-yl)oxy)ethyl)-4-Formylbenzamide is a structurally unique aldehyde ADC linker facilitating precise antibody conjugation and improved antibody-drug conjugate payload stability for enhanced therapeutic effects.

N-(2-((2,3-Dihydro-1H-Inden-5-yl)oxy)ethyl)-4-Formylbenzamide

Structure of 1225979-81-6

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C19H19NO3
Molecular Weight
309.36
Shipping
Room temperature, or blue ice upon request.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Canonical SMILES
C1CC2=C(C1)C=C(C=C2)OCCNC(=O)C3=CC=C(C=C3)C=O
InChI
InChI=1S/C19H19NO3/c21-13-14-4-6-16(7-5-14)19(22)20-10-11-23-18-9-8-15-2-1-3-17(15)12-18/h4-9,12-13H,1-3,10-11H2,(H,20,22)
InChIKey
HWYLPFDSOSJVMU-UHFFFAOYSA-N
Shipping
Room temperature, or blue ice upon request.

Pharmaceutical Applications: N-(2-((2,3-Dihydro-1H-Inden-5-yl)oxy)ethyl)-4-Formylbenzamide has gained attention in the pharmaceutical industry due to its potential as a therapeutic agent. Its unique structure, which combines a formylbenzamide group with an indenyl ether moiety, allows it to interact with various molecular targets. This compound has been explored for its anti-inflammatory properties, making it a candidate for treating conditions such as arthritis and other inflammatory diseases. By modulating key signaling pathways, it could help reduce tissue inflammation and mitigate pain associated with chronic inflammatory disorders. Additionally, its ability to influence cellular processes, such as apoptosis and cell proliferation, holds promise for cancer therapy research.

Chemical Biology and Drug Discovery: In chemical biology, N-(2-((2,3-Dihydro-1H-Inden-5-yl)oxy)ethyl)-4-Formylbenzamide serves as a valuable tool for drug discovery. Its ability to serve as a molecular probe makes it useful for investigating biological systems and identifying potential therapeutic targets. The compound can be employed in high-throughput screening assays to identify new lead molecules for drug development. Furthermore, due to its structural features, it may exhibit specificity for certain enzymes or receptors, making it a candidate for developing more targeted therapies. By understanding how it interacts with biological molecules, researchers can gain insight into the molecular mechanisms of diseases, facilitating the discovery of novel drugs.

Materials Science and Synthesis: N-(2-((2,3-Dihydro-1H-Inden-5-yl)oxy)ethyl)-4-Formylbenzamide also has potential applications in materials science, particularly in the synthesis of functional materials. The compound’s aromatic and heterocyclic components contribute to its ability to form stable bonds with other molecules, which can be leveraged in the development of polymers or composite materials with specialized properties. Its unique molecular structure allows it to serve as a building block in the creation of functionalized surfaces or coatings with specific chemical reactivity. These materials could find applications in areas such as sensors, electronics, and catalysis.

Cosmetic and Dermatological Uses: In addition to its pharmaceutical and chemical applications, N-(2-((2,3-Dihydro-1H-Inden-5-yl)oxy)ethyl)-4-Formylbenzamide is being explored in the cosmetic and dermatological sectors. The compound’s potential to modulate inflammation and influence skin cell behavior makes it a candidate for skincare formulations. It could be used in products aimed at reducing signs of aging, such as wrinkles and fine lines, by promoting skin regeneration and enhancing elasticity. Additionally, its antioxidant properties may contribute to the prevention of oxidative stress-induced skin damage. The compound's gentle action on the skin could make it an ideal ingredient for sensitive skin formulations.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Belantamab mafodotin | 3-((2,5-Dioxopyrrolidin-1-Yl)oxy)-3-Oxopropyl Acrylate | (2S)-p-SCN-Bn-NOTA | [(2-methylpropan-2-yl)oxycarbonylamino] 4-methylbenzenesulfonate | Fmoc-L-Lys(4-N3-Z)-OH | p-SCN-Bn-DOTA | DM1-SMCC | DM1-SPP | (2-pyridyldithio)-PEG1-hydrazine | (R)-8-Azido-2-(Fmoc-amino)octanoic acid | N-(2-((2,3-Dihydro-1H-Inden-5-yl)oxy)ethyl)-4-Formylbenzamide
Send Inquiry
Verification code
Inquiry Basket